NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/17/2023
Back to search
Official data from USPTO
PANPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
11/17/2023
Trademark type
Combined
Nice classes
5
Filing date
05/19/2014
Registration date
07/21/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/04/2022
Last transaction
02/04/2022
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
F-35133 LUITRE, FR
Examiner
SMITH, CYNTHIA RINALDI
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PANPHARMA, Société anonyme
Representatives
WILLIAM C. WRIGHT EPSTEIN DRANGEL LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of allergiesdiseases related to the central nervous systemimmune system diseasesautoimmune diseasesinflammatory diseasesrheumatoid arthritisankylosing spondilitisobesitydiabetesdyslipemiabrain diseaseslocomotor disorders of the central nervous systembreak downmultiple sclerosisthrombosis and cancercardiovascular diseasesrespiratory system diseasesdigestive system diseaseshaematological system and skeletal system diseasespsychiatric disordersskin and subcutaneous tissue disordersrenal and urinary disordersbronchial disordersasthmasinusitisflu-like statesfeverish achesgrowth and mineralization disordersveinolimphatic insufficiency and disorderscapillary fragility disordersacute haemorroidal episodesinfectious conditionstravel sicknesshealing of wounds and burnssleep disordersnausea and vomitingconstipationdiarrheasintestinal disordersnervousnessstresshysteriafearsanxiety and temporary tirednessneurotonic conditionsgoutcoldrhinitiscoughinfluenzasrhinopharyngitissore throatstracheitislaryngitis and bacterial and non-bacterial anginashoarsenesskickslumps and contusionseczemacholesteroldegenerationscutaneous and mucuous disordersphysical and psychic astheniamenopausemenstruation-related disordersallergic disordersgynaecological diseasesrheumatic diseasesurological diseasesgastro-enterological diseasesophtalmological diseasesdermatological diseasesgenital diseasesendocrine diseasesintestinal diseasesblood-related diseasesdiseases related to internal medicinecirculatory disordersmuscular disordersnephropathypulmonary embolismhypertensionatherothrombosisarrythmiahearing failureepilepsyschizophrenianeurotic and psychosomatic disordershyperplasiaprostatetoxoplasmosismalariamalignant and benign tumorshypercalcemiahyperuremiatuberculosiswhooping coughdiphtheriapoliomyelitisrabiesallergic reactionsmetabolic disordercontrol of allergic reactions or metabolic disorders; pharmaceutical preparations for smoking cessationpharmaceutical sedativestranquilizersdepuratives for the body; vitaminmineral supplements and vaccines for use on domestic animals and livestock for veterinary purposes; dietetic foodscrackerscakessoupmeal replacement barsfruit and vegetable granules adapted for medical use; pesticidespreparations for destroying vermin within the province of the pharmaceutical sector
Publications
History of USPTO decisions and trademark events.
36 publications found
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
11/13/2022
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
10/14/2022
INPC
INVALIDATION PROCESSED
10/14/2022
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/04/2022
C71T
CANCELLED SECTION 71
02/04/2022
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/02/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/27/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/21/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/05/2016
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
12/10/2015
XXCR
GENERIC MADRID TRANSACTION CREATED
12/10/2015
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/21/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/05/2015
PUBO
PUBLISHED FOR OPPOSITION
05/05/2015
GPNX
NOTIFICATION PROCESSED BY IB
05/02/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/15/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/15/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/15/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/28/2015
ALIE
ASSIGNED TO LIE
03/23/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/04/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/03/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/03/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/03/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/03/2015
RFNT
REFUSAL PROCESSED BY IB
09/25/2014
MAFR
APPLICATION FILING RECEIPT MAILED
09/06/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/05/2014
RFRR
REFUSAL PROCESSED BY MPU
09/05/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/05/2014
CNRT
NON-FINAL ACTION WRITTEN
09/04/2014
DOCK
ASSIGNED TO EXAMINER
09/03/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/02/2014
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
08/28/2014
Continuous trademark protection
Get notified about every new filing that threatens PANPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.